Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
GILD

Gilead

$79.40

-1.29 (-1.60%)

, GSK

GlaxoSmithKline

$36.67

0.1 (0.27%)

10:20
02/23/18
02/23
10:20
02/23/18
10:20
Conference/Events
Leerink pharmaceuticals analysts to hold an analyst/industry conference call »

Analyst Research Team…

GILD

Gilead

$79.40

-1.29 (-1.60%)

GSK

GlaxoSmithKline

$36.67

0.1 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 25

    Mar

  • 23

    Apr

Thursday
GILD

Gilead

$80.69

-0.25 (-0.31%)

, GSK

GlaxoSmithKline

$36.56

-0.13 (-0.35%)

07:06
02/22/18
02/22
07:06
02/22/18
07:06
Recommendations
Gilead, GlaxoSmithKline analyst commentary at Leerink »

Rapid adoption of Gilead…

GILD

Gilead

$80.69

-0.25 (-0.31%)

GSK

GlaxoSmithKline

$36.56

-0.13 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 23

    Apr

Wednesday
HBI

Hanesbrands

$19.93

-0.56 (-2.73%)

, JD

JD.com

$46.93

0.51 (1.10%)

08:45
02/21/18
02/21
08:45
02/21/18
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

HBI

Hanesbrands

$19.93

-0.56 (-2.73%)

JD

JD.com

$46.93

0.51 (1.10%)

DUST

Direxion Daily Gold Miners Bear 3X ETF

$26.84

2.05 (8.27%)

OIH

Oil Services Holders Trust

$24.22

-0.16 (-0.66%)

GSK

GlaxoSmithKline

$37.33

-0.37 (-0.98%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$86.15

-0.3 (-0.35%)

NOK

Nokia

$5.73

-0.03 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

  • 25

    Mar

  • 23

    Apr

Over a week ago
TBPH

Theravance Biopharma

$29.38

1.24 (4.41%)

, GSK

GlaxoSmithKline

$36.82

0.36 (0.99%)

08:43
02/15/18
02/15
08:43
02/15/18
08:43
Hot Stocks
Theravance Biopharma reports submission of Trelegy Ellipta study to EMA »

Theravance Biopharma…

TBPH

Theravance Biopharma

$29.38

1.24 (4.41%)

GSK

GlaxoSmithKline

$36.82

0.36 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 23

    Apr

  • 13

    Nov

GSK

GlaxoSmithKline

$36.46

0.19 (0.52%)

, INVA

Innoviva

$16.99

1.54 (9.97%)

05:46
02/14/18
02/14
05:46
02/14/18
05:46
Hot Stocks
GSK submits landmark IMPACT data to EMA for Trelegy Ellipta »

GlaxoSmithKline (GSK) and…

GSK

GlaxoSmithKline

$36.46

0.19 (0.52%)

INVA

Innoviva

$16.99

1.54 (9.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 23

    Apr

GILD

Gilead

$82.76

2.38 (2.96%)

, GSK

GlaxoSmithKline

09:23
02/08/18
02/08
09:23
02/08/18
09:23
Recommendations
Gilead, GlaxoSmithKline analyst commentary at Morgan Stanley »

Gilead Biktarvy approval,…

GILD

Gilead

$82.76

2.38 (2.96%)

GSK

GlaxoSmithKline

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

  • 25

    Mar

  • 23

    Apr

GSK

GlaxoSmithKline

$36.03

0.04 (0.11%)

, PFE

Pfizer

$34.98

-0.3 (-0.85%)

09:07
02/08/18
02/08
09:07
02/08/18
09:07
Hot Stocks
ViiV Healthcare announces phase 3 study of HIV two-drug regimen »

ViiV Healthcare, the…

GSK

GlaxoSmithKline

$36.03

0.04 (0.11%)

PFE

Pfizer

$34.98

-0.3 (-0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

  • 12

    Feb

  • 16

    Feb

  • 08

    Mar

  • 25

    Mar

  • 04

    Apr

  • 23

    Apr

GSK

GlaxoSmithKline

$36.03

0.04 (0.11%)

, PFE

Pfizer

$34.98

-0.3 (-0.85%)

09:05
02/08/18
02/08
09:05
02/08/18
09:05
Hot Stocks
GlaxoSmithKline, Pfizer venture files patent infringement litigation against Gilead »

ViiV Healthcare, the…

GSK

GlaxoSmithKline

$36.03

0.04 (0.11%)

PFE

Pfizer

$34.98

-0.3 (-0.85%)

GILD

Gilead

$82.76

2.38 (2.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

  • 12

    Feb

  • 12

    Feb

  • 16

    Feb

  • 08

    Mar

  • 25

    Mar

  • 04

    Apr

  • 23

    Apr

GSK

GlaxoSmithKline

$35.99

0.5 (1.41%)

07:42
02/07/18
02/07
07:42
02/07/18
07:42
Hot Stocks
GlaxoSmithKline says 2018 adjusted EPS growth uncertain due to Advair »

CEO Emma Walmsley said:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

  • 25

    Mar

  • 23

    Apr

GSK

GlaxoSmithKline

$35.99

0.5 (1.41%)

07:39
02/07/18
02/07
07:39
02/07/18
07:39
Earnings
GlaxoSmithKline reports Q4 adjusted EPS 27.2p vs. 25.5p a year ago »

Reports Q4 revenue GBP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

  • 25

    Mar

  • 23

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.